Login to Your Account



Regulatory NEWS
CEO: RESUBMISSION BY END OF THIS YEAR
Acelrx Pharmaceuticals Inc. didn't have to wait for its Sunday PDUFA date for Zalviso, but the company also didn't receive the FDA approval it sought and analysts largely expected.
LONDON – The EMA added a seventh product to the roster of biosimilar versions of Amgen Inc.'s Neupogen it has approved, giving the nod to Accofil from Accord Healthcare Ltd., of Haverhill, UK.
The European Society for Medical Oncology (ESMO), a pan-European body representing European oncologists, has warned that retrospective clinical cancer research could be outlawed in Europe if the European Parliament's legislative proposals on data protection are not overturned.
More Regulatory Headlines

Cast Your Vote

Has biotech’s bubble burst?: